When the body fights an infection or recovers from injury, the immune response can become its own threat. Excessive inflammation damages healthy tissue and kills. Scientists at the Salk Institute discovered that one dietary amino acid dramatically shifts this outcome by enlisting an unexpected ally: the kidneys.
Researchers led by Janelle Ayres found that methionine, a common amino acid people normally obtain through food, protected infected mice from organ damage, muscle wasting, and death. The protection worked through an elegant mechanism: methionine boosted kidney filtration capacity, allowing the kidneys to clear dangerous inflammatory proteins from the bloodstream through urine.
The finding reshapes how scientists think about disease survival. Rather than focusing solely on turning immune responses on or off, Ayres's team identified how the body can modulate inflammation's intensity by managing the accumulation of pro-inflammatory cytokines, the signaling proteins that trigger sickness and death.
"Pro-inflammatory cytokines are ultimately what leads to sickness and death in a lot of cases," said Katia Troha, the study's first author and a postdoctoral researcher in Ayres's lab. "The immune system has to balance inflammation to attack the invader without harming healthy cells in the body."
The research began when scientists observed that infected mice stopped eating, signaling a metabolic shift. Blood tests revealed the animals had depleted methionine levels. When researchers supplemented a second group of mice with methionine-enriched chow, the results were striking: protected from infection, these animals maintained kidney function and survived the bacterial pathogen Yersinia pseudotuberculosis.
Detailed analysis showed methionine's mechanism. The amino acid increased how efficiently the kidneys filtered blood, improved circulation to these organs, and enabled them to excrete excess cytokines in urine. Critically, this clearance did not compromise the immune system's ability to fight the infection itself.
The team tested methionine in additional disease models. In sepsis and kidney injury scenarios, the amino acid again protected mice, suggesting its benefits extend beyond single infections to broader inflammatory conditions.
Infected mice given methionine showed protection from blood-brain barrier dysfunction, a consequence of severe inflammation. They avoided the wasting and tissue damage that typically accompanies serious systemic infection. Their disease trajectory, to use Ayres's phrase, took them toward recovery rather than decline.
The implications could reach vulnerable populations. Patients with kidney disease, kidney failure, or those undergoing dialysis often struggle with inflammation that accelerates decline. Methionine supplementation might offer a mechanistically grounded intervention, though human trials have not yet been conducted.
"Our findings add to a growing body of evidence that common dietary elements can be used as medicine," Ayres said. "By studying these basic protective mechanisms, we reveal surprising new ways to shift individuals that are fated to develop disease and die onto trajectories of health and survival."
The research, published in Cell Metabolism, underscores a larger principle: small biological changes, including dietary factors, can produce outsized effects on whether a person survives serious illness. The same insult that kills one patient leaves another relatively unscathed. Understanding what shapes that difference has been Ayres's career focus, and methionine offers a tangible example of how nutrition might tip outcomes.
Scientists caution that the findings remain preliminary. The work was conducted in mice, not humans, and the mechanisms may not translate directly across species. Future research will explore whether other amino acids produce similar effects, how methionine works at a molecular level, and whether supplementation benefits real patients facing sepsis, infection, or inflammatory disease.
For now, the researchers urge against taking methionine supplements based on this study alone. But the door has opened to a possibility: that something as simple as a dietary addition could someday shift the difference between life and death for a critically ill patient.
Author Jessica Williams: "This isn't revolutionary yet, but it reframes the kidney as an active player in survival rather than a passive filter, and that's a meaningful shift in how we think about managing inflammation."
Comments